knowledge -WSS

knowledge

author：knowledge 2025-10-02 22:27:03 - browse：275

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum. It’s not too late to join us virtually. Check out details here.

It’s a travel-shortened week for me, so in this newsletter, I decided to dive deep into PDS Biotech and its experimental drug for head and neck cancer. PDS is what I’d call a biotech cult stock.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： 3 questions for the future of Biden's cancer moonshot

leisure time

WSS

Covid's long

Kim Kardashian sparks debate on benefits of full

CDC overhauls leadership of center that led response to Covid

GOP presidential candidates start declaring their loyalty

Colorectal cancer study finds potential in overlooked immune cell

Novo acquires Inversago for up to $1 billion

leisure time

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Physician executives need more than on

Cancer drug shortages should be causing more outrage

Why age limits for politicians are a terrible idea

Apple is now the first public company to be valued at $3 trillion

Some of the ways extreme heat will change life as we know it

As demand for Covid shots wanes, Moderna seeks its next success

Why age limits for politicians are a terrible idea

Continuity nursing helped my family in our darkest PICU moments

An innovative path out of biotech’s “valley of death”

Wikipedia

Maui funeral service workers on devastation of fires: 'I'm in shock'

An innovative path out of biotech’s “valley of death”

Was Amgen transparent enough on FDA's concern on cancer drug?

Where are patients getting their prescriptions for GLP

Covid's long

Why age limits for politicians are a terrible idea

explore

focus

leisure time

focus